RESUMEN
Scientific support about the concept of using molecular data for risk stratification and tailoring health-care interventions to the individual--a strategy broadly defined as molecular medicine (MM)--is accumulating. Molecular-based health-care technologies are beginning to enter clinical practice, but their use has revealed many scientific, economic, and organizational barriers to the effective delivery of targeted health care. We conducted a qualitative interview study to describe the MM landscape, with an emphasis on eliciting policy recommendations for the field from a broad range of stakeholders in MM and health care. Molecular medicine has widespread support but will require changes in how molecular-based technologies are evaluated, how health care is financed and delivered, and how clinicians and consumers are trained and prepared for its use. In particular, researchers and developers need to become active participants in a variety of clinical integration strategies to realize the promise of MM.
Asunto(s)
Medicina Clínica/organización & administración , Prestación Integrada de Atención de Salud/organización & administración , Regulación Gubernamental , Costos de la Atención en Salud , Política de Salud , Biología Molecular/organización & administración , Farmacogenética/organización & administración , Medicina Clínica/economía , Medicina Clínica/legislación & jurisprudencia , Prestación Integrada de Atención de Salud/economía , Prestación Integrada de Atención de Salud/legislación & jurisprudencia , Pruebas Genéticas/economía , Pruebas Genéticas/legislación & jurisprudencia , Guías como Asunto , Encuestas de Atención de la Salud , Necesidades y Demandas de Servicios de Salud , Investigación sobre Servicios de Salud , Humanos , Entrevistas como Asunto , Biología Molecular/economía , Biología Molecular/legislación & jurisprudencia , Técnicas de Diagnóstico Molecular/economía , Selección de Paciente , Farmacogenética/economía , Farmacogenética/legislación & jurisprudencia , Estados UnidosRESUMEN
The 1997 National Institutes of Health (NIH) Consensus Conference on Cystic Fibrosis (CF) testing recommended that carrier screening be offered to all pregnant women and couples planning a pregnancy. We surveyed 492 Maryland Ob-Gyns before and after the consensus conference to: (1) assess whether obstetricians changed their practice regarding CF carrier testing, and (2) identify the factors associated with changing practice patterns, including awareness of the statement, and knowledge about CF. Fifty-six percent (275) responded to the first mail questionnaire and 107 obstetricians responded to both questionnaires. In 1998, only 18% of respondents to the second questionnaire were familiar with the NIH statement, but 43% reported discussing testing with patients with no family history, a significant increase from 1997, when only 20% reported discussing testing. Less than one-third correctly answered six multiple-choice knowledge questions about CF and carrier testing. In multivariate analysis, knowledge and familiarity with the NIH consensus statement were not associated with beginning to discuss CF carrier testing after the CF conference with their patients without a family history.
Asunto(s)
Consensus Development Conferences, NIH as Topic , Fibrosis Quística/prevención & control , Tamización de Portadores Genéticos , Pruebas Genéticas/estadística & datos numéricos , Adhesión a Directriz , Conocimientos, Actitudes y Práctica en Salud , Obstetricia/estadística & datos numéricos , Médicos/psicología , Adulto , Estudios Transversales , Fibrosis Quística/epidemiología , Fibrosis Quística/genética , Femenino , Asesoramiento Genético , Humanos , Maryland , Persona de Mediana Edad , Educación del Paciente como Asunto , Relaciones Médico-Paciente , Embarazo , Práctica Profesional/estadística & datos numéricos , Práctica Profesional/tendencias , Sensibilidad y Especificidad , Encuestas y Cuestionarios , Estados UnidosRESUMEN
BACKGROUND: A 1995 workforce study conducted by RAND estimated a large current surplus of eye care providers in the United States. Due to data limitations of the RAND study and the outdated optometric workforce information available, the American Optometric Association contracted with Abt Associates to conduct a study to project future workforce requirements for optometry. METHODS: We collected extensive data on both the supply (work hours, retirement rates, new entrants) and demand (patient encounters and associated time requirements) of optometrists. These data were collected from a survey using stratified random sampling of 1,100 practicing optometrists and were used to develop workforce projections for optometry through the year 2030. Projections were calculated using a forecasting tool that can be used to derive workforce and training requirements under a range of future scenarios. RESULTS: Workforce projections suggest an excess supply of optometrists is likely over the next 20 years. Over the next five years, approximately 550 optometrists are expected to retire each year, while more than 1,100 optometrists enter practice annually. Patient encounter volume is projected to increase steadily, but the effects of this increase are largely offset by an anticipated decrease in optometrist time requirements for routine eye examinations. DISCUSSION: To reduce the size of the anticipated excess supply, optometry may want to focus on ways that demand can be increased. One way to increase demand is through greater convergence between the actual demand for eye care services and the underlying public health need for eye care.
Asunto(s)
Necesidades y Demandas de Servicios de Salud/estadística & datos numéricos , Fuerza Laboral en Salud/estadística & datos numéricos , Optometría , Adulto , Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad , Optometría/estadística & datos numéricos , Sociedades Médicas , Encuestas y Cuestionarios , Estados UnidosRESUMEN
More information is needed about the relative effectiveness of prophylactic surgery, chemoprevention, and surveillance in reducing breast and ovarian cancer risk in women with an inherited susceptibility mutation. We assessed practical and ethical barriers to conducting randomized clinical trials (RCTs) to compare preventive interventions for breast and ovarian cancer. Eighty-seven at-risk women who attended an education and counseling session about BRCA1/2 testing were asked about their willingness to participate in hypothetical research studies for breast and ovarian cancer risk reduction. In addition, 247 Maryland physicians from five specialties completed a mail survey including a question about their likelihood of recommending RCT participation to an at-risk woman. Nineteen percent of at-risk women reported willingness to participate in a hypothetical RCT for breast cancer risk reduction and 17% for ovarian cancer risk reduction. Women with children and women likely to have a prophylactic mastectomy if found to have a susceptibility mutation were significantly more willing to participate in an RCT. A majority of women would be willing to participate in nonrandomized trials or registries. Fifty-two percent of physicians responded that they would be likely to recommend RCT participation to a woman carrying a breast cancer susceptibility mutation. Oncologists were the most likely to recommend an RCT. Although the results of nonrandomized trials may be difficult to interpret because of such issues as selection bias. Greater feasibility combined with fewer ethical concerns make nonrandomized trials a more viable alternative to randomized trials for evaluation of preventive interventions for breast and ovarian cancer when prophylactic surgery is one of the treatments being evaluated.
Asunto(s)
Neoplasias de la Mama/prevención & control , Neoplasias de la Mama/cirugía , Ética Médica , Neoplasias Ováricas/prevención & control , Neoplasias Ováricas/cirugía , Selección de Paciente , Ensayos Clínicos Controlados Aleatorios como Asunto , Adulto , Neoplasias de la Mama/genética , Neoplasias de la Mama/psicología , Recolección de Datos , Femenino , Predisposición Genética a la Enfermedad , Humanos , Neoplasias Ováricas/genética , Neoplasias Ováricas/psicología , Factores de Riesgo , Salud de la MujerRESUMEN
PURPOSE/OBJECTIVES: To compare outcomes of pretest education about breast cancer susceptibility testing provided by nurses and genetic counselors. DESIGN: Two-group, post-test only evaluation of an educational intervention. SETTING: A tertiary care hospital. SAMPLE: 87 women who had a first-degree relative with premenopausal breast cancer; six specially-trained providers (four genetic counselors and two nurses). METHODS: Self-administered questionnaire completed immediately following education sessions. MAIN RESEARCH VARIABLES: Subjects' understanding of the limitations of testing, perceived autonomy in decision making, and satisfaction; partnership as perceived by subjects and providers. FINDINGS: After the sessions, 62% of subjects understood the limitations of testing, 98% reported a high degree of perceived autonomy in decision making, 81% were highly satisfied with the session, and 91% reported forming a partnership with their providers. Lower perceived partnership reported by genetic counselors was the only significant difference by provider type. CONCLUSIONS: With training and supervision, nurses and genetic counselors can be equally effective in providing education about genetic testing for breast cancer susceptibility in research settings. Additional research is needed to determine the outcomes of education provided in clinical settings. IMPLICATIONS FOR NURSING PRACTICE: As the demand for education about genetic testing for cancer susceptibility increases, nurses need to be educated and trained to provide this service.
Asunto(s)
Neoplasias de la Mama/enfermería , Asesoramiento Genético , Predisposición Genética a la Enfermedad , Educación del Paciente como Asunto , Adulto , Neoplasias de la Mama/genética , Estudios de Evaluación como Asunto , Femenino , Asesoramiento Genético/métodos , Asesoramiento Genético/estadística & datos numéricos , Predisposición Genética a la Enfermedad/genética , Humanos , Persona de Mediana Edad , Educación del Paciente como Asunto/métodos , Educación del Paciente como Asunto/estadística & datos numéricos , Satisfacción del Paciente/estadística & datos numéricos , Selección de Paciente , Selección de Personal , Recursos HumanosRESUMEN
OBJECTIVES: We offered education, counseling, and family-based BRCA1/2 testing to women at increased risk of breast cancer and assessed (a) their reasons for participating and (b) whether source of recruitment, desire to help research (altruism), and the need to communicate with their affected relative about testing distinguish those who did and those who did not complete each phase of our protocol. MATERIALS AND METHODS: We sent invitations to 403 women who had completed a questionnaire on BRCA1/2 testing, 178 of whom were considered high risk because they had more than one relative on the same side of the family with early-onset breast cancer. RESULTS: Among the 132 high-risk respondents from the mid-Atlantic states (where testing was offered), 36% (n = 47) were interested in counseling. Those who actually attended counseling were more likely to have some college education, a higher perceived risk of breast cancer, and a greater fear of stigma and were less likely to have a daughter than those who did not attend. The reasons for attending that were rated "very important" were to learn about the test (80%), to have the test (43%), and to help research (38%). High-risk women were eligible for testing only if their affected relative was willing to be tested and tested positive. After the session, 83% intended to ask their affected relative to be tested, but only half of the affected relatives actually came for pretest counseling. The proportion of participants who ultimately involved an affected relative was 2.5 times higher among women from a clinical population (25%) than among those from a registry population (10%); in this latter population, an altruistic desire to help research was a greater motivator for participation than interest in being tested. CONCLUSIONS: Source of recruitment influences both motivations to attend education and counseling and actual testing behavior. These results have implications for interpretation of findings from studies in research settings as well as for informed consent and decision-making in the context of family-based testing.
Asunto(s)
Altruismo , Neoplasias de la Mama/genética , Neoplasias de la Mama/prevención & control , Toma de Decisiones , Familia/psicología , Predisposición Genética a la Enfermedad/genética , Pruebas Genéticas/psicología , Conocimientos, Actitudes y Práctica en Salud , Selección de Paciente , Mujeres/psicología , Adulto , Comunicación , Femenino , Genes BRCA1 , Humanos , Persona de Mediana Edad , Motivación , Factores de Riesgo , Encuestas y CuestionariosRESUMEN
PURPOSE: To learn the extent to which HMOs and academic genetic centers (1) are involved in predictive genetic tests for common, complex disorders and (2) interact with each other. METHODS: Surveys of HMO medical directors and directors of U.S. academic genetic centers. RESULTS: In 1996, approximately 28% of HMOs were covering predictive tests for breast and colon cancer, but 75% of all medical directors said their HMO would consider policies regarding predictive testing in the next 5 years. Approximately 80% of directors of academic genetic centers said they provided genetic counseling services for common adult-onset disorders for patients covered by managed care organizations (MCOs), but they ranked the volume of services they provide for pediatric and prenatal indications much higher. Most academic genetic centers (72%) have contracts with MCOs. CONCLUSION: Although genetic services are being provided by academic genetic centers to patients who are members of managed care organizations, many patients with whom genetic testing for adult onset disorders is discussed may never see a geneticist. Academic genetic centers should educate nongeneticist professionals about the use of tests for common disorders.
Asunto(s)
Centros Médicos Académicos/tendencias , Genética/tendencias , Sistemas Prepagos de Salud , Enfermedad de Alzheimer/diagnóstico , Neoplasias de la Mama/diagnóstico , Neoplasias del Colon/diagnóstico , Asesoramiento Genético/tendencias , Pruebas Genéticas/tendencias , Genética/educación , Humanos , Encuestas y Cuestionarios , Recursos HumanosRESUMEN
OBJECTIVE: To describe patient-obstetrician communication during the first prenatal visit and its relationship to physician gender and patient satisfaction. METHODS: The first prenatal visit of 87 women with 21 obstetricians (11 male and ten female) was audiotaped and analyzed using the Roter Interaction Analysis System. Patient satisfaction was measured by postvisit questionnaire. RESULTS: Communication during first prenatal visits was largely biomedical, with little psychosocial or social discussion. Male physicians conducted longer visits than females (26 minutes versus 21.9 minutes, P < .05) and engaged in more facilitative communication (ie, making sure they were understood and providing direction and orientation) and explicit statements of concern and partnership (z > 1.96, P < .05). Female physicians devoted more communication to agreements, disagreements, and laughter than males (z > 1.96, P < .05). Satisfaction with physicians' emotional responsiveness and informational partnership was related to female physician gender and a variety of task-focused and affective communication variables. CONCLUSION: Communication and satisfaction between women and obstetricians during initial prenatal visits is related to physician gender and patient satisfaction. Male physicians conducted longer visits but women were more satisfied with female physicians.
Asunto(s)
Comunicación , Identidad de Género , Obstetricia , Satisfacción del Paciente , Relaciones Médico-Paciente , Adulto , Femenino , Humanos , Recién Nacido , Masculino , Educación del Paciente como Asunto , Embarazo , Atención PrenatalRESUMEN
PURPOSE: To determine what consumers and providers would want to discuss about breast cancer susceptibility testing (BCST) and their preferred role in testing decisions. METHODS: We surveyed 426 at-risk women, 143 nurse practitioners, and 296 physicians in five specialties in Maryland. RESULTS: All groups believe it is important to discuss how the chance of breast cancer can be reduced and what the chances are of getting breast cancer if the test is positive. Both provider groups attributed more importance than consumers to discussing whether cancer can occur if the test is negative. Discussing the risk of depression and anxiety was more important to providers than consumers. Eighty-two percent of women would want their providers to make a recommendation about testing, but only 43% of nurse practitioners and 68% of physicians would do so. Eighteen percent of physicians underestimated the importance of informed consent for testing and 34% of discussing the risk of insurance discrimination. Fewer than 6% of women, if found to have a mutation, would be likely to undergo prophylactic mastectomy, whereas 12% of nurse practitioners and 34% of physicians would be likely to recommend such surgery. One third of respondents in all three groups supported testing a 13-year old daughter of a mutation-carrier. CONCLUSION: Physicians should place greater value on informed consent and discussing practical aspects of testing, and physicians and nurse practitioners should pay more attention to the limitations of testing children, insurance discrimination, and consumers' desire for provider recommendations. In light of the limited discordance between nurse practitioners and consumers, nurse practitioners can play an increasing role in education and counseling about BCST.
Asunto(s)
Actitud del Personal de Salud , Neoplasias de la Mama/genética , Pruebas Genéticas/psicología , Adulto , Neoplasias de la Mama/prevención & control , Neoplasias de la Mama/psicología , Toma de Decisiones , Susceptibilidad a Enfermedades , Femenino , Humanos , Consentimiento Informado , Medicina , Persona de Mediana Edad , Enfermeras Practicantes/psicología , Educación del Paciente como Asunto , Factores de Riesgo , Especialización , Encuestas y CuestionariosRESUMEN
OBJECTIVE: To document the content and accuracy of discussions about prenatal genetic testing between obstetric providers and pregnant women. METHODS: The first prenatal visits of 169 pregnant women with 21 obstetricians and 19 certified nurse-midwives were audiotaped and analyzed for whether a discussion of family history or genetic testing took place and if so, its length, content, and accuracy. RESULTS: Family history was discussed in 60% of visits, maternal serum marker screening in 60%, second-trimester ultrasonography for fetal anomalies in 34%, and for women at least 35 years old, amniocentesis or chorionic villus sampling (CVS) in 98%. The length of discussions of genetic testing averaged 2.5 minutes for women younger than 35 years of age and 6.9 minutes for older women. Topics discussed most often were the practical details of testing, the purpose of testing, and the fact that testing is voluntary. Discussions seldom were comprehensive. Obstetricians were more likely to make a recommendation about testing than were nurse-midwives and were less likely to indicate that testing is voluntary. Most women were satisfied with the amount of information, and the majority of women of advanced maternal age had made a decision about amniocentesis or CVS by the end of the visit. CONCLUSION: The information about genetic testing provided in the first prenatal visit is inadequate for ensuring informed autonomous decision-making. Guidelines addressing the content of these discussions should be developed with input from obstetricians, nurse-midwives, genetic counselors, and pregnant women.
Asunto(s)
Pruebas Genéticas , Anamnesis , Educación del Paciente como Asunto , Diagnóstico Prenatal , Adulto , Comunicación , Femenino , Tamización de Portadores Genéticos , Marcadores Genéticos , Humanos , Enfermeras Obstetrices , Obstetricia , EmbarazoAsunto(s)
Tamización de Portadores Genéticos , Enfermedades Genéticas Congénitas/prevención & control , Pruebas Genéticas , Enfermedades Genéticas Congénitas/genética , Política de Salud , Humanos , Consentimiento Informado , Anamnesis , Obstetricia , Educación del Paciente como Asunto , Proyectos Piloto , Vigilancia de la Población , Factores de RiesgoAsunto(s)
Actitud , Neoplasias de la Mama , Educación Médica , Pruebas Genéticas , Médicos , Estudiantes , Factores de Edad , Recolección de Datos , Medicina Familiar y Comunitaria , Femenino , Cirugía General , Asesoramiento Genético , Humanos , Consentimiento Informado , Medicina Interna , Maryland , Tamizaje Masivo , Medicina , Embarazo , Mujeres Embarazadas , Diagnóstico Prenatal , Facultades de Medicina , Especialización , MujeresRESUMEN
The number of influenza and influenza-related deaths is alarmingly high, yet mean vaccination adherence rates among the high-risk elderly population remain at only 20%. The present study investigates the use of an inexpensive voice-mail system, TeleMinder, as a method of increasing influenza vaccination adherence among a subpopulation of elders identified as low adherers. The first group of older people received no intervention. Group 2 received a voice-mail message informing them of the cost, time, date, and location of an influenza vaccination clinic. Group 3 was exposed to posted and verbal announcements alone. Group 4 both received voice mail and was exposed to posted and verbal announcements. Vaccination adherence levels for groups 1 through 4 were 1.5%, 11.8%, 7.4%, and 37.5%, respectively. Voice mail significantly increased vaccination adherence either alone or in combination with posted and verbal announcements. These findings suggest that voice mail provides an inexpensive means of increasing influenza vaccination rates.